Tenn. Code Ann. § 63-6-244 — TN Code / Title 63 / Chapter 6 / Section 63-6-244
Interventional pain management
Status: in_force

(a) A physician licensed pursuant to this chapter may only practice interventional pain management if the licensee is either: (1) Board certified through the American Board of Medical Specialties (ABMS) or the American Board of Physician Specialties (ABPS)/American Association of Physician Specialists (AAPS) in one of the following medical specialties: (A) Anesthesiology; (B) Neurological surgery; (C) Orthopedic surgery; (D) Physical medicine and rehabilitation; (E) Radiology; or (F) Any other board certified physician who has completed an ABMS subspecialty board in pain medicine or completed an ACGME-accredited pain fellowship; (2) A recent graduate in a medical specialty listed in subdivision (a)(1) not yet eligible to apply for ABMS or ABPS/AAPS board certification; provided, that there is a practice relationship with a physician who meets the requirements of subdivision (a)(1) or an osteopathic physician who meets the requirements of § 63-9-121(a)(1) ; (3) A licensee who is not board certified in one of the specialties listed in subdivision (a)(1) but is board certified in a different ABMS or ABPS/AAPS specialty and has completed a post-graduate training program in interventional pain management approved by the board; (4) A licensee who serves as a clinical instructor in pain medicine at an accredited Tennessee medical training program; or (5) A licensee who has an active pain management practice in a clinic accredited in outpatient interdisciplinary pain rehabilitation by the commission on accreditation of rehabilitation facilities or any successor organization. (b) For purposes of this section, "interventional pain management" is the practice of performing invasive procedures involving any portion of the spine, spinal cord, sympathetic nerves of the spine or block of major peripheral nerves of the spine in any setting not licensed under title 68, chapter 11. (c) The board is authorized to define through rulemaking the scope and length of the practice relationship established in subdivision (a)(2). (d) A physician who provides direct supervision of an advanced practice registered nurse or a physician's assistant pursuant to § 63-7-126 or § 63-19-107 must meet the requirements set forth in subdivision (a)(1) or (a)(3). (e) A physician who violates this section is subject to disciplinary action by the board pursuant to § 63-6-214 , including, but not limited to, civil penalties of up to one thousand dollars ($1,000) for every day this section is violated. Amended by 2016 Tenn. Acts, ch. 980, s 9, eff. 7/1/2016. Acts 2012 , ch. 961, § 4.
(a) A physician licensed pursuant to this chapter may only practice interventional pain management if the licensee is either: (1) Board certified through the American Board of Medical Specialties (ABMS) or the American Board of Physician Specialties (ABPS)/American Association of Physician Specialists (AAPS) in one of the following medical specialties: (A) Anesthesiology; (B) Neurological surgery; (C) Orthopedic surgery; (D) Physical medicine and rehabilitation; (E) Radiology; or (F) Any other board certified physician who has completed an ABMS subspecialty board in pain medicine or completed an ACGME-accredited pain fellowship; (2) A recent graduate in a medical specialty listed in subdivision (a)(1) not yet eligible to apply for ABMS or ABPS/AAPS board certification; provided, that there is a practice relationship with a physician who meets the requirements of subdivision (a)(1) or an osteopathic physician who meets the requirements of § 63-9-121(a)(1) ; (3) A licensee who is not board certified in one of the specialties listed in subdivision (a)(1) but is board certified in a different ABMS or ABPS/AAPS specialty and has completed a post-graduate training program in interventional pain management approved by the board; (4) A licensee who serves as a clinical instructor in pain medicine at an accredited Tennessee medical training program; or (5) A licensee who has an active pain management practice in a clinic accredited in outpatient interdisciplinary pain rehabilitation by the commission on accreditation of rehabilitation facilities or any successor organization.
(1) Board certified through the American Board of Medical Specialties (ABMS) or the American Board of Physician Specialties (ABPS)/American Association of Physician Specialists (AAPS) in one of the following medical specialties: (A) Anesthesiology; (B) Neurological surgery; (C) Orthopedic surgery; (D) Physical medicine and rehabilitation; (E) Radiology; or (F) Any other board certified physician who has completed an ABMS subspecialty board in pain medicine or completed an ACGME-accredited pain fellowship;
(A) Anesthesiology;
(B) Neurological surgery;
(C) Orthopedic surgery;
(D) Physical medicine and rehabilitation;
(E) Radiology; or
(F) Any other board certified physician who has completed an ABMS subspecialty board in pain medicine or completed an ACGME-accredited pain fellowship;
(2) A recent graduate in a medical specialty listed in subdivision (a)(1) not yet eligible to apply for ABMS or ABPS/AAPS board certification; provided, that there is a practice relationship with a physician who meets the requirements of subdivision (a)(1) or an osteopathic physician who meets the requirements of § 63-9-121(a)(1) ;
(3) A licensee who is not board certified in one of the specialties listed in subdivision (a)(1) but is board certified in a different ABMS or ABPS/AAPS specialty and has completed a post-graduate training program in interventional pain management approved by the board;
(4) A licensee who serves as a clinical instructor in pain medicine at an accredited Tennessee medical training program; or
(5) A licensee who has an active pain management practice in a clinic accredited in outpatient interdisciplinary pain rehabilitation by the commission on accreditation of rehabilitation facilities or any successor organization.
(b) For purposes of this section, "interventional pain management" is the practice of performing invasive procedures involving any portion of the spine, spinal cord, sympathetic nerves of the spine or block of major peripheral nerves of the spine in any setting not licensed under title 68, chapter 11.
(c) The board is authorized to define through rulemaking the scope and length of the practice relationship established in subdivision (a)(2).
(d) A physician who provides direct supervision of an advanced practice registered nurse or a physician's assistant pursuant to § 63-7-126 or § 63-19-107 must meet the requirements set forth in subdivision (a)(1) or (a)(3).
(e) A physician who violates this section is subject to disciplinary action by the board pursuant to § 63-6-214 , including, but not limited to, civil penalties of up to one thousand dollars ($1,000) for every day this section is violated.
Amended by 2016 Tenn. Acts, ch. 980, s 9, eff. 7/1/2016.
Acts 2012 , ch. 961, § 4.
Tenn. Code Ann. § 63-3-108 — TN Code / Title 63 / Chapter 3 / Section 63-3-108
Exemptions
Status: in_force

This chapter shall not apply to the commissioned physicians and surgeons of the United States army, navy, air force or marine hospital service in the actual performance of their official duties, nor to physicians and surgeons or to osteopathic physicians and surgeons regularly licensed under the laws of this state, nor to visiting podiatrists called into consultation in this state from another state where they are duly qualified under the laws of that state to practice podiatry. Acts 1931, ch. 31, § 2; 1949, ch. 152, § 1; C. Supp. 1950, § 7182.3 (Williams, § 7182.4); modified; Acts 1973, ch. 393, § 6; 1976, ch. 796, § 1; T.C.A. (orig. ed.), § 63-308.
This chapter shall not apply to the commissioned physicians and surgeons of the United States army, navy, air force or marine hospital service in the actual performance of their official duties, nor to physicians and surgeons or to osteopathic physicians and surgeons regularly licensed under the laws of this state, nor to visiting podiatrists called into consultation in this state from another state where they are duly qualified under the laws of that state to practice podiatry.
Acts 1931, ch. 31, § 2; 1949, ch. 152, § 1; C. Supp. 1950, § 7182.3 (Williams, § 7182.4); modified; Acts 1973, ch. 393, § 6; 1976, ch. 796, § 1; T.C.A. (orig. ed.), § 63-308.
Tenn. Code Ann. § 63-30-107 — TN Code / Title 63 / Chapter 30 / Section 63-30-107
Use of title
Status: in_force

Reflexologists registered by the state may hold themselves out as "registered certified reflexologists" and may use the title or the initials "RCR" following the person's name in connection with the profession. No person may use the title "registered certified reflexologist" or the initials "RCR" unless registered in accordance with this chapter. Acts 2001, ch. 389, § 8.
Reflexologists registered by the state may hold themselves out as "registered certified reflexologists" and may use the title or the initials "RCR" following the person's name in connection with the profession. No person may use the title "registered certified reflexologist" or the initials "RCR" unless registered in accordance with this chapter.
Acts 2001, ch. 389, § 8.
Tenn. Code Ann. § 63-10-205 — TN Code / Title 63 / Chapter 10 / Section 63-10-205
Consultation on drugs by board to department of health
Status: in_force

(a) The board shall, at the request of the commissioner of health, provide consultation to the department of health regarding drugs to be issued by the department or by a local health clinic. (b) The department of health shall develop policies and protocols for inventory controls, accountability, repackaging, security, storage and issuance of drugs by state and local health departments. The commissioner shall appoint a state or regional pharmacist to oversee these activities. (c) The commissioner of health is authorized to promulgate rules and regulations to effectuate the purposes of this section. Amended by 2014 Tenn. Acts, ch. 585, s 1, eff. 7/1/2014. Acts 1996, ch. 651, § 5; T.C.A. § 63-10-405 .
(a) The board shall, at the request of the commissioner of health, provide consultation to the department of health regarding drugs to be issued by the department or by a local health clinic.
(b) The department of health shall develop policies and protocols for inventory controls, accountability, repackaging, security, storage and issuance of drugs by state and local health departments. The commissioner shall appoint a state or regional pharmacist to oversee these activities.
(c) The commissioner of health is authorized to promulgate rules and regulations to effectuate the purposes of this section.
Amended by 2014 Tenn. Acts, ch. 585, s 1, eff. 7/1/2014.
Acts 1996, ch. 651, § 5; T.C.A. § 63-10-405 .
Tenn. Code Ann. § 63-10-214 — TN Code / Title 63 / Chapter 10 / Section 63-10-214
Centralized prescription processing - Licensing - Rules
Status: in_force

(a) Each pharmacy participating in centralized prescription processing shall be licensed by the board of pharmacy. (b) The board shall promulgate rules relative to centralized prescription processing, including, but not limited to, the usage of common electronic files or a common database. Acts 2008 , ch. 966, § 1.
(a) Each pharmacy participating in centralized prescription processing shall be licensed by the board of pharmacy.
(b) The board shall promulgate rules relative to centralized prescription processing, including, but not limited to, the usage of common electronic files or a common database.
Acts 2008 , ch. 966, § 1.
Tenn. Code Ann. § 63-7-116 — TN Code / Title 63 / Chapter 7 / Section 63-7-116
License revocation or suspension procedure - Reissuance - Contested case hearings
Status: in_force

(a) Any person may prefer charges against a nurse for violation of any grounds of discipline mentioned in § 63-7-115 . The charges shall be in writing and submitted to the board unless they originate with the board or a member thereof. (b) Unless the charges are dismissed without a hearing by the board as unfounded or not warranting further investigation, the board shall, within ninety (90) days from the date on which the charges are preferred, set a time, date and place for a hearing on the charges. The date set for the hearing shall not be more than six (6) months from the date on which the charges are preferred. (c) A copy of the charges, together with the notice of the time and place of the hearing, shall be furnished to the accused, which may be done by registered mail directed to the address furnished to the board at the time of registration, at least thirty (30) days before the date fixed for the hearing. (d) (1) The chair or the vice chair of the board has the power to administer oaths, issue subpoenas and enforce the attendance of witnesses and the production of books, records and papers at any hearing on any matter that the board has power to investigate. (2) If any witness fails or refuses to obey a subpoena issued by it, the board is authorized to make application to any court of record in this state within the jurisdiction of which the witness is found or resides; and the court shall have power to attach the body of the witness and compel the witness to appear before the board and give testimony or produce books, records or papers as ordered. Any failure to obey the court order may be punished by the court issuing the order as a contempt. (3) Each witness who appears before the board by order of the board shall receive for attendance the compensation provided by law for attendance of witnesses in a court of record, which shall be paid from the funds of the board in the same manner as all other expenses of the board are paid. (e) At the hearing, the accused shall have the right to appear personally and by counsel to cross-examine witnesses to produce evidence and witnesses, and shall also have the right to have subpoenas issued by the board to compel the attendance of all witnesses considered by the parties to be necessary to a full and complete hearing. (f) After the hearing, if a majority of the members of the board present vote in favor of finding the accused guilty of any of the charges, the board shall suspend or revoke the certificate of registration of the accused as in its judgment the offense deserves. (g) Review of the action of the board in suspending or revoking any license shall be pursuant to title 27, chapter 9. (h) The board may reissue any license that it has revoked if a majority of the members of the board present vote in favor of the reissuance of the license for reasons the board may consider sufficient. (i) Notwithstanding any other law to the contrary, for purposes of contested case hearings and disciplinary matters, three (3) or more members shall constitute a quorum and the board chair is authorized, when it is deemed necessary, to split the board into panels of three (3) or more members, each to conduct contested case hearings or disciplinary matters. A majority vote of the members present on any duly constituted panel shall be required to authorize board action in disciplinary matters and contested case hearings. The board chair shall have the authority to appoint board members to serve, as necessary, on the panels regardless of the grand division from which the appointed member was chosen or the member's status as a nurse or non-nurse member. The participation of a non-nurse board member creates no rights in any individual concerning the composition of any panel in any disciplinary matter or contested case hearing. The unavailability of a member of any panel before rendition of a final order shall not require substitution of another member unless the unavailability results in there being less than the quorum required by this section for contested case hearings or disciplinary matters. Any substitute required shall use any existing record and may conduct any further proceedings as are necessary in the interest of justice. A decision by the panel shall be deemed an order of the board. Acts 1967, ch. 78, § 25; 1972, ch. 523, § 3; T.C.A., § 63-753; Acts 1984, ch. 755, § 7; 1985, ch. 39, §§ 8, 9, 12; 2008 , ch. 849, § 1.
(a) Any person may prefer charges against a nurse for violation of any grounds of discipline mentioned in § 63-7-115 . The charges shall be in writing and submitted to the board unless they originate with the board or a member thereof.
(b) Unless the charges are dismissed without a hearing by the board as unfounded or not warranting further investigation, the board shall, within ninety (90) days from the date on which the charges are preferred, set a time, date and place for a hearing on the charges. The date set for the hearing shall not be more than six (6) months from the date on which the charges are preferred.
(c) A copy of the charges, together with the notice of the time and place of the hearing, shall be furnished to the accused, which may be done by registered mail directed to the address furnished to the board at the time of registration, at least thirty (30) days before the date fixed for the hearing.
(d) (1) The chair or the vice chair of the board has the power to administer oaths, issue subpoenas and enforce the attendance of witnesses and the production of books, records and papers at any hearing on any matter that the board has power to investigate. (2) If any witness fails or refuses to obey a subpoena issued by it, the board is authorized to make application to any court of record in this state within the jurisdiction of which the witness is found or resides; and the court shall have power to attach the body of the witness and compel the witness to appear before the board and give testimony or produce books, records or papers as ordered. Any failure to obey the court order may be punished by the court issuing the order as a contempt. (3) Each witness who appears before the board by order of the board shall receive for attendance the compensation provided by law for attendance of witnesses in a court of record, which shall be paid from the funds of the board in the same manner as all other expenses of the board are paid.
(1) The chair or the vice chair of the board has the power to administer oaths, issue subpoenas and enforce the attendance of witnesses and the production of books, records and papers at any hearing on any matter that the board has power to investigate.
(2) If any witness fails or refuses to obey a subpoena issued by it, the board is authorized to make application to any court of record in this state within the jurisdiction of which the witness is found or resides; and the court shall have power to attach the body of the witness and compel the witness to appear before the board and give testimony or produce books, records or papers as ordered. Any failure to obey the court order may be punished by the court issuing the order as a contempt.
(3) Each witness who appears before the board by order of the board shall receive for attendance the compensation provided by law for attendance of witnesses in a court of record, which shall be paid from the funds of the board in the same manner as all other expenses of the board are paid.
(e) At the hearing, the accused shall have the right to appear personally and by counsel to cross-examine witnesses to produce evidence and witnesses, and shall also have the right to have subpoenas issued by the board to compel the attendance of all witnesses considered by the parties to be necessary to a full and complete hearing.
(f) After the hearing, if a majority of the members of the board present vote in favor of finding the accused guilty of any of the charges, the board shall suspend or revoke the certificate of registration of the accused as in its judgment the offense deserves.
(g) Review of the action of the board in suspending or revoking any license shall be pursuant to title 27, chapter 9.
(h) The board may reissue any license that it has revoked if a majority of the members of the board present vote in favor of the reissuance of the license for reasons the board may consider sufficient.
(i) Notwithstanding any other law to the contrary, for purposes of contested case hearings and disciplinary matters, three (3) or more members shall constitute a quorum and the board chair is authorized, when it is deemed necessary, to split the board into panels of three (3) or more members, each to conduct contested case hearings or disciplinary matters. A majority vote of the members present on any duly constituted panel shall be required to authorize board action in disciplinary matters and contested case hearings. The board chair shall have the authority to appoint board members to serve, as necessary, on the panels regardless of the grand division from which the appointed member was chosen or the member's status as a nurse or non-nurse member. The participation of a non-nurse board member creates no rights in any individual concerning the composition of any panel in any disciplinary matter or contested case hearing. The unavailability of a member of any panel before rendition of a final order shall not require substitution of another member unless the unavailability results in there being less than the quorum required by this section for contested case hearings or disciplinary matters. Any substitute required shall use any existing record and may conduct any further proceedings as are necessary in the interest of justice. A decision by the panel shall be deemed an order of the board.
Acts 1967, ch. 78, § 25; 1972, ch. 523, § 3; T.C.A., § 63-753; Acts 1984, ch. 755, § 7; 1985, ch. 39, §§ 8, 9, 12; 2008 , ch. 849, § 1.
Tenn. Code Ann. § 63-6-302 — TN Code / Title 63 / Chapter 6 / Section 63-6-302
Part definitions
Status: in_force

As used in this part, unless the context otherwise requires: (1) "Advanced illness" means a progressive disease or medical or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of current federal drug administration approved and available treatments, and that, without life-sustaining procedures, will soon result in death; (2) "Adverse event" means any untoward medical occurrence associated with the use of an investigational drug, biological product, or device in humans, regardless if drug-related; (3) "Eligible patient" means an individual who meets all of the following conditions: (A) Has an advanced illness, attested to by the patient's treating physician and confirmed by a second physician; (B) Has considered all other treatment options currently approved by the United States food and drug administration, and is unable to enter, or be accepted within one (1) week after applying to, a clinical trial within fifty (50) miles of the individual's home; (C) Has received a recommendation from the patient's physician for an investigational drug, biological product, or device; (D) Has given written, informed consent for the use of the investigational drug, biological product, or device; and (E) Has documentation from the patient's physician that the patient meets the requirements of this subdivision (3); (4) "Investigational drug, biological product, or device" means a drug, biological product, or device that has successfully completed phase 1 of a clinical trial as documented by the National Institutes of Health but has not yet been approved for general use by the federal food and drug administration (FDA) and remains under investigation in a clinical trial that is approved by the FDA; and (5) "Written, informed consent" means a written document that is signed by the patient, the patient's parent, if the patient is a minor, the patient's legal guardian, or the patient's attorney-in-fact designated by the patient under title 34, chapter 6, part 2, and attested to by the patient's physician and a witness, and that, at a minimum, includes all of the following: (A) An explanation of the currently approved products and treatments for the disease or condition from which the patient suffers; (B) An attestation that the patient concurs with the patient's physician in believing that all currently approved and conventionally recognized treatments are unlikely to prolong the patient's life; (C) Clear identification of the specific proposed investigational drug, biological product, or device that the patient is seeking to use; (D) A description of the potentially best and worst outcomes of using the investigational drug, biological product, or device and a realistic description of the most likely outcome. The description shall include the possibility that new, unanticipated, different, or worse symptoms might result and that death could be hastened by the proposed treatment. The description shall be based on the physician's knowledge of the proposed treatment in conjunction with an awareness of the patient's condition; (E) A release of liability relative to the treating physician, licensed healthcare providers, hospital, and manufacturer of the investigational drug, biological product, procedure, or device; (F) A statement that the patient's health plan or third-party administrator and provider are not obligated to pay for any care or treatments consequent to the use of the investigational drug, biological product, or device, unless they are specifically required to do so by law or contract; (G) A statement that the patient's eligibility for hospice care may be withdrawn if the patient begins curative treatment with the investigational drug, biological product, or device and that care may be reinstated if this treatment ends and the patient meets hospice eligibility requirements; and (H) A statement that the patient understands that the patient is liable for all expenses consequent to the use of the investigational drug, biological product, or device and that this liability extends to the patient's estate, unless a contract between the patient and the manufacturer of the drug, biological product, or device states otherwise. Added by 2015 Tenn. Acts, ch. 376, s 1, eff. 7/1/2015.
As used in this part, unless the context otherwise requires:
(1) "Advanced illness" means a progressive disease or medical or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of current federal drug administration approved and available treatments, and that, without life-sustaining procedures, will soon result in death;
(2) "Adverse event" means any untoward medical occurrence associated with the use of an investigational drug, biological product, or device in humans, regardless if drug-related;
(3) "Eligible patient" means an individual who meets all of the following conditions: (A) Has an advanced illness, attested to by the patient's treating physician and confirmed by a second physician; (B) Has considered all other treatment options currently approved by the United States food and drug administration, and is unable to enter, or be accepted within one (1) week after applying to, a clinical trial within fifty (50) miles of the individual's home; (C) Has received a recommendation from the patient's physician for an investigational drug, biological product, or device; (D) Has given written, informed consent for the use of the investigational drug, biological product, or device; and (E) Has documentation from the patient's physician that the patient meets the requirements of this subdivision (3);
(A) Has an advanced illness, attested to by the patient's treating physician and confirmed by a second physician;
(B) Has considered all other treatment options currently approved by the United States food and drug administration, and is unable to enter, or be accepted within one (1) week after applying to, a clinical trial within fifty (50) miles of the individual's home;
(C) Has received a recommendation from the patient's physician for an investigational drug, biological product, or device;
(D) Has given written, informed consent for the use of the investigational drug, biological product, or device; and
(E) Has documentation from the patient's physician that the patient meets the requirements of this subdivision (3);
(4) "Investigational drug, biological product, or device" means a drug, biological product, or device that has successfully completed phase 1 of a clinical trial as documented by the National Institutes of Health but has not yet been approved for general use by the federal food and drug administration (FDA) and remains under investigation in a clinical trial that is approved by the FDA; and
(5) "Written, informed consent" means a written document that is signed by the patient, the patient's parent, if the patient is a minor, the patient's legal guardian, or the patient's attorney-in-fact designated by the patient under title 34, chapter 6, part 2, and attested to by the patient's physician and a witness, and that, at a minimum, includes all of the following: (A) An explanation of the currently approved products and treatments for the disease or condition from which the patient suffers; (B) An attestation that the patient concurs with the patient's physician in believing that all currently approved and conventionally recognized treatments are unlikely to prolong the patient's life; (C) Clear identification of the specific proposed investigational drug, biological product, or device that the patient is seeking to use; (D) A description of the potentially best and worst outcomes of using the investigational drug, biological product, or device and a realistic description of the most likely outcome. The description shall include the possibility that new, unanticipated, different, or worse symptoms might result and that death could be hastened by the proposed treatment. The description shall be based on the physician's knowledge of the proposed treatment in conjunction with an awareness of the patient's condition; (E) A release of liability relative to the treating physician, licensed healthcare providers, hospital, and manufacturer of the investigational drug, biological product, procedure, or device; (F) A statement that the patient's health plan or third-party administrator and provider are not obligated to pay for any care or treatments consequent to the use of the investigational drug, biological product, or device, unless they are specifically required to do so by law or contract; (G) A statement that the patient's eligibility for hospice care may be withdrawn if the patient begins curative treatment with the investigational drug, biological product, or device and that care may be reinstated if this treatment ends and the patient meets hospice eligibility requirements; and (H) A statement that the patient understands that the patient is liable for all expenses consequent to the use of the investigational drug, biological product, or device and that this liability extends to the patient's estate, unless a contract between the patient and the manufacturer of the drug, biological product, or device states otherwise.
(A) An explanation of the currently approved products and treatments for the disease or condition from which the patient suffers;
(B) An attestation that the patient concurs with the patient's physician in believing that all currently approved and conventionally recognized treatments are unlikely to prolong the patient's life;
(C) Clear identification of the specific proposed investigational drug, biological product, or device that the patient is seeking to use;
(D) A description of the potentially best and worst outcomes of using the investigational drug, biological product, or device and a realistic description of the most likely outcome. The description shall include the possibility that new, unanticipated, different, or worse symptoms might result and that death could be hastened by the proposed treatment. The description shall be based on the physician's knowledge of the proposed treatment in conjunction with an awareness of the patient's condition;
(E) A release of liability relative to the treating physician, licensed healthcare providers, hospital, and manufacturer of the investigational drug, biological product, procedure, or device;
(F) A statement that the patient's health plan or third-party administrator and provider are not obligated to pay for any care or treatments consequent to the use of the investigational drug, biological product, or device, unless they are specifically required to do so by law or contract;
(G) A statement that the patient's eligibility for hospice care may be withdrawn if the patient begins curative treatment with the investigational drug, biological product, or device and that care may be reinstated if this treatment ends and the patient meets hospice eligibility requirements; and
(H) A statement that the patient understands that the patient is liable for all expenses consequent to the use of the investigational drug, biological product, or device and that this liability extends to the patient's estate, unless a contract between the patient and the manufacturer of the drug, biological product, or device states otherwise.
Added by 2015 Tenn. Acts, ch. 376, s 1, eff. 7/1/2015.
Tenn. Code Ann. § 63-3-201 — TN Code / Title 63 / Chapter 3 / Section 63-3-201
Part definitions
Status: in_force

As used in this part, unless the context otherwise requires: (1) "Board" means the board that licenses and regulates podiatrists in Tennessee in part 1 of this chapter; (2) "Commissioner" means the commissioner of health; (3) "Custom fabricated and fitted device" means an orthosis, prosthesis or pedorthic device that is fabricated to original measurements or to a mold for use by a patient in accordance with a prescription from a health care practitioner authorized by law to write such prescriptions and that requires substantial clinical and technical judgment in its design and fitting; (4) "Custom fitted device" means a prefabricated orthosis, prosthesis or pedorthic device sized or modified for use by the patient in accordance with a prescription from a health care practitioner authorized by law to write such prescriptions that requires substantial clinical judgment and substantive alteration for appropriate use; (5) "Department" means the department of health; (6) "Director" means the director of the division of health related boards; (7) "Division" means the division of health related boards; (8) "Facility" means the business location where orthotic, prosthetic or pedorthic care is provided. In the case of an orthotic/prosthetic facility, the orthotic/prosthetic facility has the appropriate clinical and laboratory space and equipment to provide comprehensive orthotic or prosthetic care; and, in the case of a pedorthic facility, the pedorthic facility has the appropriate clinical space and equipment to provide pedorthic care. Licensed orthotists, prosthetists and pedorthists must be available to either provide care or to supervise the provision of care by nonlicensed staff; (9) "Licensed orthotist" means a person who is licensed under this part to practice orthotics and who represents the person to the public by title or description of services that includes the term "orthotic," "orthotist," "brace" or a similar title or description of services; (10) "Licensed pedorthist" means a person who is licensed under this part to practice pedorthics and who represents the person to the public by the title or description of services that includes the term "pedorthic," "pedorthist" or a similar title or description of services; (11) "Licensed prosthetist" means a person who is licensed under this part to practice prosthetics and who represents the person to the public by title or description of services that includes the term "prosthetic," "prosthetist," "artificial limb" or a similar title or description of services; (12) "Off-the-shelf device" means a prefabricated prosthesis or orthosis sized or modified for use by the patient in accordance with a prescription from a health care practitioner authorized by law to write such prescriptions that does not require substantial clinical judgment and substantive alteration for appropriate use; (13) "Orthosis" means a custom designed, fabricated, fitted or modified device to correct, support or compensate for a neuro-musculoskeletal disorder or acquired condition. "Orthosis" does not include fabric or elastic supports, corsets, arch supports, low-temperature plastic splints, trusses, elastic hoses, canes, crutches, soft cervical collars, dental appliances or other similar devices that are carried in stock and sold without modification as over-the-counter items by a drug store, department store, corset shop or surgical supply facility; (14) "Orthotic and prosthetic education program" means a course of instruction accredited by the Commission on Accreditation of Allied Health Education Programs (CAAHEP), consisting of: (A) An adequate curriculum of college level training and instruction in math, physics, biology, chemistry and psychology; and (B) A specific curriculum in orthotic or prosthetic courses, including: (i) Lectures covering pertinent anatomy, biomechanics, pathomechanics, prosthetic-orthotic components and materials, training and functional capabilities, prosthetic or orthotic performance evaluation, prescription considerations, etiology of amputations and disease processes necessitating prosthetic or orthotic use and medical management; (ii) Subject matter related to pediatric and geriatric problems; (iii) Instruction in acute care techniques, such as immediate and early post-surgical prosthetics and fracture bracing techniques; and (iv) Lectures, demonstrations and laboratory experiences related to the entire process of measuring, casting, fitting, fabricating, aligning and completing prostheses or orthoses; (15) "Orthotics" means the science and practice of evaluating, measuring, designing, fabricating, assembling, fitting, adjusting or servicing an orthosis, under an order from a licensed health care practitioner authorized by law to issue such an order, for the correction or alleviation of neuromuscular or musculoskeletal dysfunction, disease, injury or deformity; (16) "Orthotist" means an allied health professional who is specifically trained and educated to provide or manage the provision of a custom-designed, fabricated, modified and fitted external orthosis to an orthotic patient, based on a clinical assessment and a prescription from a health care practitioner authorized by law to write such prescriptions, to restore physiological function or cosmesis; (17) "Over-the-counter device" means a prefabricated, mass-produced device that is prepackaged and requires no professional advice or judgment in either size selection or use, including fabric or elastic supports, corsets, generic arch supports and elastic hose; (18) "Pedorthic device" means therapeutic footwear, foot orthoses for use at the ankle or below and modified footwear made for therapeutic purposes, as prescribed by a licensed health care practitioner authorized by law to issue such prescription. "Pedorthic device" does not include nontherapeutic accommodative inlays or nontherapeutic accommodative footwear, regardless of method of manufacture, shoe modifications made for nontherapeutic purposes, unmodified, over-the-counter shoes or prefabricated foot care products; (19) "Pedorthic education program" means a course of instruction accredited by the Board for Certification in Pedorthics, consisting of: (A) A basic curriculum of instruction in foot-related pathology of diseases, anatomy and biomechanics; (B) A specific curriculum in pedorthic courses, including lectures covering shoes, foot orthoses and shoe modifications, pedorthic components and materials, training and functional capabilities, pedorthic performance evaluation, prescription considerations, etiology of disease processes necessitating use of pedorthic devices, medical management and subject matter related to pediatric and geriatric problems; and (C) Lectures, demonstrations, and laboratory experiences related to the entire process of measuring and casting, fitting, fabricating, aligning and completing pedorthic devices; (20) "Pedorthics" means the science and practice of evaluating, measuring, designing, fabricating, assembling, fitting, adjusting or servicing a pedorthic device, under an order from a licensed health care practitioner authorized by law to issue such order for the correction or alleviation of neuromuscular or musculoskeletal dysfunction, disease, injury or deformity; (21) "Pedorthist" means a person who measures, designs, fabricates, fits or services pedorthic devices and assists in the formulation of the order of pedorthic devices, as ordered by a licensed health care practitioner authorized by law to issue such order for the support or correction of disabilities caused by neuro-musculoskeletal diseases, injuries or deformities; (22) "Person" means a natural person; (23) "Prosthesis" means a custom designed, fabricated, fitted or modified device to replace an absent external limb, for the purpose of restoring physiological function or cosmesis. "Prosthesis" does not include artificial eyes, ears or dental appliances, cosmetic devices such as artificial breasts, eyelashes or wigs or other devices that do not have a significant impact on the musculoskeletal functions of the body; (24) "Prosthetics" means the science and practice of evaluating, measuring, designing, fabricating, assembling, fitting, adjusting or servicing a prosthesis, under an order from a licensed health care practitioner authorized by law to issue such order; (25) "Prosthetist" means an allied health professional who is specifically trained and educated to provide or manage the provision of a custom designed, fabricated, modified and fitted external limb prosthesis to a prosthetic patient, based on a clinical assessment and a prescription from a health care practitioner authorized to write such prescriptions, to restore physiological function or cosmesis; (26) "Prosthetist/Orthotist" means a person who practices both disciplines of prosthetics and orthotics and who represents the person to the public by title or by description of services; and (27) "Resident" means a person who has completed an education program in either orthotics or prosthetics and is continuing such person's clinical education in a residency program approved by the board. Acts 2005, ch. 380, § 1.
As used in this part, unless the context otherwise requires:
(1) "Board" means the board that licenses and regulates podiatrists in Tennessee in part 1 of this chapter;
(2) "Commissioner" means the commissioner of health;
(3) "Custom fabricated and fitted device" means an orthosis, prosthesis or pedorthic device that is fabricated to original measurements or to a mold for use by a patient in accordance with a prescription from a health care practitioner authorized by law to write such prescriptions and that requires substantial clinical and technical judgment in its design and fitting;
(4) "Custom fitted device" means a prefabricated orthosis, prosthesis or pedorthic device sized or modified for use by the patient in accordance with a prescription from a health care practitioner authorized by law to write such prescriptions that requires substantial clinical judgment and substantive alteration for appropriate use;
(5) "Department" means the department of health;
(6) "Director" means the director of the division of health related boards;
(7) "Division" means the division of health related boards;
(8) "Facility" means the business location where orthotic, prosthetic or pedorthic care is provided. In the case of an orthotic/prosthetic facility, the orthotic/prosthetic facility has the appropriate clinical and laboratory space and equipment to provide comprehensive orthotic or prosthetic care; and, in the case of a pedorthic facility, the pedorthic facility has the appropriate clinical space and equipment to provide pedorthic care. Licensed orthotists, prosthetists and pedorthists must be available to either provide care or to supervise the provision of care by nonlicensed staff;
(9) "Licensed orthotist" means a person who is licensed under this part to practice orthotics and who represents the person to the public by title or description of services that includes the term "orthotic," "orthotist," "brace" or a similar title or description of services;
(10) "Licensed pedorthist" means a person who is licensed under this part to practice pedorthics and who represents the person to the public by the title or description of services that includes the term "pedorthic," "pedorthist" or a similar title or description of services;
(11) "Licensed prosthetist" means a person who is licensed under this part to practice prosthetics and who represents the person to the public by title or description of services that includes the term "prosthetic," "prosthetist," "artificial limb" or a similar title or description of services;
(12) "Off-the-shelf device" means a prefabricated prosthesis or orthosis sized or modified for use by the patient in accordance with a prescription from a health care practitioner authorized by law to write such prescriptions that does not require substantial clinical judgment and substantive alteration for appropriate use;
(13) "Orthosis" means a custom designed, fabricated, fitted or modified device to correct, support or compensate for a neuro-musculoskeletal disorder or acquired condition. "Orthosis" does not include fabric or elastic supports, corsets, arch supports, low-temperature plastic splints, trusses, elastic hoses, canes, crutches, soft cervical collars, dental appliances or other similar devices that are carried in stock and sold without modification as over-the-counter items by a drug store, department store, corset shop or surgical supply facility;
(14) "Orthotic and prosthetic education program" means a course of instruction accredited by the Commission on Accreditation of Allied Health Education Programs (CAAHEP), consisting of: (A) An adequate curriculum of college level training and instruction in math, physics, biology, chemistry and psychology; and (B) A specific curriculum in orthotic or prosthetic courses, including: (i) Lectures covering pertinent anatomy, biomechanics, pathomechanics, prosthetic-orthotic components and materials, training and functional capabilities, prosthetic or orthotic performance evaluation, prescription considerations, etiology of amputations and disease processes necessitating prosthetic or orthotic use and medical management; (ii) Subject matter related to pediatric and geriatric problems; (iii) Instruction in acute care techniques, such as immediate and early post-surgical prosthetics and fracture bracing techniques; and (iv) Lectures, demonstrations and laboratory experiences related to the entire process of measuring, casting, fitting, fabricating, aligning and completing prostheses or orthoses;
(A) An adequate curriculum of college level training and instruction in math, physics, biology, chemistry and psychology; and
(B) A specific curriculum in orthotic or prosthetic courses, including: (i) Lectures covering pertinent anatomy, biomechanics, pathomechanics, prosthetic-orthotic components and materials, training and functional capabilities, prosthetic or orthotic performance evaluation, prescription considerations, etiology of amputations and disease processes necessitating prosthetic or orthotic use and medical management; (ii) Subject matter related to pediatric and geriatric problems; (iii) Instruction in acute care techniques, such as immediate and early post-surgical prosthetics and fracture bracing techniques; and (iv) Lectures, demonstrations and laboratory experiences related to the entire process of measuring, casting, fitting, fabricating, aligning and completing prostheses or orthoses;
(i) Lectures covering pertinent anatomy, biomechanics, pathomechanics, prosthetic-orthotic components and materials, training and functional capabilities, prosthetic or orthotic performance evaluation, prescription considerations, etiology of amputations and disease processes necessitating prosthetic or orthotic use and medical management;
(ii) Subject matter related to pediatric and geriatric problems;
(iii) Instruction in acute care techniques, such as immediate and early post-surgical prosthetics and fracture bracing techniques; and
(iv) Lectures, demonstrations and laboratory experiences related to the entire process of measuring, casting, fitting, fabricating, aligning and completing prostheses or orthoses;
(15) "Orthotics" means the science and practice of evaluating, measuring, designing, fabricating, assembling, fitting, adjusting or servicing an orthosis, under an order from a licensed health care practitioner authorized by law to issue such an order, for the correction or alleviation of neuromuscular or musculoskeletal dysfunction, disease, injury or deformity;
(16) "Orthotist" means an allied health professional who is specifically trained and educated to provide or manage the provision of a custom-designed, fabricated, modified and fitted external orthosis to an orthotic patient, based on a clinical assessment and a prescription from a health care practitioner authorized by law to write such prescriptions, to restore physiological function or cosmesis;
(17) "Over-the-counter device" means a prefabricated, mass-produced device that is prepackaged and requires no professional advice or judgment in either size selection or use, including fabric or elastic supports, corsets, generic arch supports and elastic hose;
(18) "Pedorthic device" means therapeutic footwear, foot orthoses for use at the ankle or below and modified footwear made for therapeutic purposes, as prescribed by a licensed health care practitioner authorized by law to issue such prescription. "Pedorthic device" does not include nontherapeutic accommodative inlays or nontherapeutic accommodative footwear, regardless of method of manufacture, shoe modifications made for nontherapeutic purposes, unmodified, over-the-counter shoes or prefabricated foot care products;
(19) "Pedorthic education program" means a course of instruction accredited by the Board for Certification in Pedorthics, consisting of: (A) A basic curriculum of instruction in foot-related pathology of diseases, anatomy and biomechanics; (B) A specific curriculum in pedorthic courses, including lectures covering shoes, foot orthoses and shoe modifications, pedorthic components and materials, training and functional capabilities, pedorthic performance evaluation, prescription considerations, etiology of disease processes necessitating use of pedorthic devices, medical management and subject matter related to pediatric and geriatric problems; and (C) Lectures, demonstrations, and laboratory experiences related to the entire process of measuring and casting, fitting, fabricating, aligning and completing pedorthic devices;
(A) A basic curriculum of instruction in foot-related pathology of diseases, anatomy and biomechanics;
(B) A specific curriculum in pedorthic courses, including lectures covering shoes, foot orthoses and shoe modifications, pedorthic components and materials, training and functional capabilities, pedorthic performance evaluation, prescription considerations, etiology of disease processes necessitating use of pedorthic devices, medical management and subject matter related to pediatric and geriatric problems; and
(C) Lectures, demonstrations, and laboratory experiences related to the entire process of measuring and casting, fitting, fabricating, aligning and completing pedorthic devices;
(20) "Pedorthics" means the science and practice of evaluating, measuring, designing, fabricating, assembling, fitting, adjusting or servicing a pedorthic device, under an order from a licensed health care practitioner authorized by law to issue such order for the correction or alleviation of neuromuscular or musculoskeletal dysfunction, disease, injury or deformity;
(21) "Pedorthist" means a person who measures, designs, fabricates, fits or services pedorthic devices and assists in the formulation of the order of pedorthic devices, as ordered by a licensed health care practitioner authorized by law to issue such order for the support or correction of disabilities caused by neuro-musculoskeletal diseases, injuries or deformities;
(22) "Person" means a natural person;
(23) "Prosthesis" means a custom designed, fabricated, fitted or modified device to replace an absent external limb, for the purpose of restoring physiological function or cosmesis. "Prosthesis" does not include artificial eyes, ears or dental appliances, cosmetic devices such as artificial breasts, eyelashes or wigs or other devices that do not have a significant impact on the musculoskeletal functions of the body;
(24) "Prosthetics" means the science and practice of evaluating, measuring, designing, fabricating, assembling, fitting, adjusting or servicing a prosthesis, under an order from a licensed health care practitioner authorized by law to issue such order;
(25) "Prosthetist" means an allied health professional who is specifically trained and educated to provide or manage the provision of a custom designed, fabricated, modified and fitted external limb prosthesis to a prosthetic patient, based on a clinical assessment and a prescription from a health care practitioner authorized to write such prescriptions, to restore physiological function or cosmesis;
(26) "Prosthetist/Orthotist" means a person who practices both disciplines of prosthetics and orthotics and who represents the person to the public by title or by description of services; and
(27) "Resident" means a person who has completed an education program in either orthotics or prosthetics and is continuing such person's clinical education in a residency program approved by the board.
Acts 2005, ch. 380, § 1.
Tenn. Code Ann. § 63-6-207 — TN Code / Title 63 / Chapter 6 / Section 63-6-207
Application for certificate - Special training licenses - St. Jude Children's Research Hospital global collaboration license
Status: in_force

(a) A person desiring to practice medicine or surgery in this state shall make application in writing to the board or via online application, which shall be accompanied by: (1) If a United States or Canadian medical school graduate: (A) A certificate from a medical school whose curriculum is approved by the American Medical Association or its extant accreditation program for medical education, or its successor; (B) A nonrefundable application fee as set by the board and by an examination fee prescribed in this section; (C) Evidence of the satisfactory completion of: (i) A one-year United States training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor; or (ii) A primary specialty training program that is accredited by the Royal College of Physicians and Surgeons of Canada and that is of a duration of not less than four (4) years; (D) Sufficient evidence of good moral character; and (E) Evidence of being legally entitled to live or work in the United States if the person is not a citizen of the United States or Canada; (2) If an international medical school graduate: (A) A certificate from a medical school whose curriculum is judged to be acceptable by the board; (B) A copy of a permanent Educational Commission for Foreign Medical Graduates (ECFMG) certificate; (C) A nonrefundable application fee as set by the board and by an examination fee prescribed in this section; (D) Sufficient evidence of good moral character; (E) Evidence of being a citizen of the United States or Canada, or legally entitled to live or work in the United States; and (F) Evidence of satisfactory completion of a three-year post-graduate training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor. Such person may apply to the board for licensure or testing in accordance with this chapter within twelve (12) months of completion of the post-graduate training program if satisfactory performance in such program is demonstrated to the satisfaction of the board. (b) All applicants shall present themselves before the board or the board's administrative designee for examination. The board may question in such subjects as the board may deem appropriate. As its qualifying examination, the board accepts the Federation Licensing Examination (FLEX), and/or the National Board of Medical Examiners examination and/or the United States Medical Licensing Examination or its successor examination. Applicants shall successfully complete the United States Medical Licensing Examination within ten (10) years from the date of whichever step of the examination was successfully completed first. An applicant is considered to have successfully completed a step of the examination on the date that the step was taken and not the date on which the passing score was made public by the examination agency; provided, however, that the board is authorized to promulgate rules and regulations creating exceptions that will extend the ten-year time frame provided in this subsection (b). In addition, the board reserves the right to write its own state board examination or contract with other national testing organizations. The board reserves the right to designate its administrative staff to administer the licensing examinations and to collect such application and examination fees as the board, in its discretion, may deem necessary. (c) The members of the board also have the right to examine all applicants in such oral examinations as they may deem necessary. (d) The board is authorized in its discretion to issue special training licenses to medical interns, residents and fellows who have met all other qualifications for licensure contained in this chapter and the rules and regulations promulgated pursuant thereto, with the exception of having completed the necessary residency or training programs required by subdivision (a)(1)(C) and/or (a)(2)(F) and the licensure examination. The board also is authorized to promulgate rules and regulations to implement this new licensure category. The initial set of these rules may be processed as emergency rules pursuant to the Uniform Administrative Procedures Act, compiled in title 4, chapter 5. These special training licenses will be governed by the following: (1) (A) Such licenses shall be issued only to medical interns, residents and fellows while participating in a training program of one of the accredited medical schools or of one of such medical school's affiliated teaching hospitals in Tennessee, performing duties assigned to meet the requirements of such program, and while under the supervision and control of a physician fully licensed to practice medicine in Tennessee; (B) No person holding a special training license is permitted to practice medicine outside of such person's duties and responsibilities in the training program without being fully licensed to practice medicine in Tennessee. Termination of participation in the training program for which the special license was issued for any reason terminates that license; (C) It is the responsibility of the program director or the dean responsible for the training program to submit the necessary information and applications on behalf of each applicant. It also is the responsibility of the program director or the dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason; and (D) The board may impose fees to accompany each individual application for a special training license. (2) (A) (i) Notwithstanding subdivision (d)(1), medical students, interns, residents, and clinical fellows who do not hold a special training license pursuant to this subsection (d) are exempt from the requirement of a license to practice medicine or surgery in this state when such medical students, interns, residents, and clinical fellows are participating in a training program of one (1) of the accredited medical schools or of one (1) of its affiliated teaching hospitals in this state, performing duties assigned to meet the requirements of the training program, and while under the supervision and control of a physician fully licensed to practice medicine or surgery in this state. No such student, intern, resident, or clinical fellow is permitted to practice medicine or surgery outside of the person's duties and responsibilities in the training program without being fully licensed to practice medicine or surgery in this state; (ii) It is the responsibility of the program director or the dean responsible for the training program to apply to the board for an exemption for each such medical student, intern, resident, or clinical fellow. Moreover, it is the responsibility of such program director or dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason; (B) The board may impose a fee to accompany each application for exemption; (C) Eligibility for the exemption provided for in this subdivision (d)(2) shall apply to all eligible persons in training on April 8, 1994, or thereafter. (e) The board or the board's designee is specifically authorized to conduct applicant interviews periodically as it deems necessary on a case by case basis. (f) (1) (A) The general assembly finds that St. Jude Children's Research Hospital is unique as a research center hospital in this state and this nation for protocol-based therapy and treatment of children and adolescents with newly diagnosed untreated or suspected cancer, HIV infections, or certain hematologic, immunologic, or genetic diseases. St. Jude Children's Research Hospital's experts are involved in research and treatment in the fields of hematology, oncology, bone marrow transplantation, immunology, genetic diseases and infectious diseases. The hospital's research involves both basic and clinical science and it is a National Cancer Institute Comprehensive Cancer Center. The general assembly finds that supporting research and treatment by qualified physicians and researchers at St. Jude Children's Research Hospital by means of a special St. Jude Children's Research Hospital global collaboration license would substantially benefit the state, the practice of medicine and the health of persons benefitting from treatment or research conducted at the hospital. (B) The board is authorized in its discretion to issue a special St. Jude Children's Research Hospital global collaboration license to physicians who have met all other qualifications for licensure contained in this chapter and the rules and regulation promulgated pursuant to this chapter, with the exception of having completed the necessary residency or training programs required by subdivision (a)(1)(C) or (a)(2)(F). The board is also authorized to promulgate rules and regulations to implement this new special licensure category. (2) These special St. Jude Children's Research Hospital global collaboration licenses will be governed by the following: (A) Such license shall be issued only to physicians while employed by St. Jude Children's Research Hospital; (B) No person holding a special St. Jude Children's Research Hospital global collaboration license is permitted to practice medicine outside of such person's duties and responsibilities as an employee of St. Jude Children's Hospital without being fully licensed to practice medicine in Tennessee. Termination of employment with St. Jude Children's Research Hospital for any reason terminates the special license; (C) It is the responsibility of St. Jude Children's Research Hospital to submit the necessary information and applications on behalf of each applicant. It is also the responsibility of St. Jude Children's Research Hospital to notify the board of the termination of the applicant's employment; and (D) The board may impose fees to accompany each individual application for this special license. (g) (1) The board may issue a foreign training license of limited duration to an international medical school graduate who has successfully completed the examination as described in subsection (b) upon finding sufficient evidence that the international medical school graduate demonstrates competency as determined by the board, and: (A) Completed a postgraduate training program of a minimum of three (3) years in the graduate's licensing country; and (B) Has otherwise practiced as a medical professional performing the duties of a physician for the last three (3) years outside the United States. (2) An applicant under subdivision (g)(1) must submit sufficient evidence that the applicant is an international medical school graduate and has an offer for employment as a physician at a healthcare provider that operates in this state and has a postgraduate training program accredited by the accreditation council for graduate medical education in place. (3) An international medical school graduate who is granted a foreign training license under subdivision (g)(1) must only provide medical services at a healthcare provider that has in place a postgraduate training program accredited by the accreditation council for graduate medical education. (4) The board may grant a full and unrestricted license to practice medicine to a foreign training licensee under subdivision (g)(1) who is in good standing and has actively practiced medicine in this state for two (2) years after the date of foreign training licensure. (5) As used in this subsection (g), "healthcare provider" means an individual, entity, corporation, person, or organization, whether for profit or nonprofit, that furnishes, bills, or is paid for a healthcare procedure or service delivery in the normal course of business, and includes, but is not limited to, a health system, hospital, hospital-based facility, freestanding emergency facility, and urgent care clinic. (h) (1) The board may issue a temporary license of limited duration to an international medical school graduate who has successfully completed the examination as described in subsection (b) upon finding sufficient evidence that the international medical school graduate demonstrates competency as determined by the board and has completed a one-year postgraduate training program in the United States. (2) Subdivision (g)(3) does not apply to an international medical school graduate who is granted a temporary license under subdivision (h)(1). (3) The board may grant a full and unrestricted license to practice medicine to a temporary licensee under subdivision (h)(1) who is in good standing and has actively practiced medicine in this state for two (2) years after the date of temporary licensure. (i) The board is authorized in its discretion to issue limited licenses to physicians who have been out of clinical practice for an extended period of time or who have been, or are at the time of their application, engaged exclusively in administrative medicine. The board may promulgate rules prescribing any other conditions or requirements with respect to the issuance of a limited license pursuant to this subsection (i). Amended by 2024 Tenn. Acts, ch. 929,s 1, eff. 1/1/2025. Amended by 2023 Tenn. Acts, ch. 211, s 1, eff. 7/1/2024. Amended by 2022 Tenn. Acts, ch. 1083, s 2, eff. 5/27/2022. Amended by 2022 Tenn. Acts, ch. 747, s 1, eff. 3/24/2022. Amended by 2016 Tenn. Acts, ch. 632, s 1, eff. 7/1/2016. Amended by 2014 Tenn. Acts, ch. 949,s 6, eff. 7/1/2014. Acts 1901, ch. 78, § 6; Shan., § 3609a18; Code 1932, § 6923; Acts 1945, ch. 181, § 3; C. Supp. 1950, § 6923; Acts 1975, ch. 355, § 14; impl. am. Acts 1976, ch. 575, § 1; T.C.A. (orig. ed.), § 63-611; Acts 1982, ch. 905, § 4; 1985, ch. 468, §§ 1, 2; 1988, ch. 912, § 1; 1989, ch. 302, § 1; 1989, ch. 523, §§ 41, 42; 1990, ch. 1002, § 1; 1990, ch. 1055, §§ 1, 3; 1993, ch. 404, § 8; 1994, ch. 732, § 2; 1995, ch. 97, §§ 1-3; 1995, ch. 329, § 1; 1998, ch. 877, § 1; 2003 , ch. 11, § 1; 2004, ch. 562, § 1; 2006, ch. 774, §§ 1, 2; 2009 , ch. 566, § 12; 2010 , ch. 724, § 1; 2010 , ch. 976, § 1.
(a) A person desiring to practice medicine or surgery in this state shall make application in writing to the board or via online application, which shall be accompanied by: (1) If a United States or Canadian medical school graduate: (A) A certificate from a medical school whose curriculum is approved by the American Medical Association or its extant accreditation program for medical education, or its successor; (B) A nonrefundable application fee as set by the board and by an examination fee prescribed in this section; (C) Evidence of the satisfactory completion of: (i) A one-year United States training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor; or (ii) A primary specialty training program that is accredited by the Royal College of Physicians and Surgeons of Canada and that is of a duration of not less than four (4) years; (D) Sufficient evidence of good moral character; and (E) Evidence of being legally entitled to live or work in the United States if the person is not a citizen of the United States or Canada; (2) If an international medical school graduate: (A) A certificate from a medical school whose curriculum is judged to be acceptable by the board; (B) A copy of a permanent Educational Commission for Foreign Medical Graduates (ECFMG) certificate; (C) A nonrefundable application fee as set by the board and by an examination fee prescribed in this section; (D) Sufficient evidence of good moral character; (E) Evidence of being a citizen of the United States or Canada, or legally entitled to live or work in the United States; and (F) Evidence of satisfactory completion of a three-year post-graduate training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor. Such person may apply to the board for licensure or testing in accordance with this chapter within twelve (12) months of completion of the post-graduate training program if satisfactory performance in such program is demonstrated to the satisfaction of the board.
(1) If a United States or Canadian medical school graduate: (A) A certificate from a medical school whose curriculum is approved by the American Medical Association or its extant accreditation program for medical education, or its successor; (B) A nonrefundable application fee as set by the board and by an examination fee prescribed in this section; (C) Evidence of the satisfactory completion of: (i) A one-year United States training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor; or (ii) A primary specialty training program that is accredited by the Royal College of Physicians and Surgeons of Canada and that is of a duration of not less than four (4) years; (D) Sufficient evidence of good moral character; and (E) Evidence of being legally entitled to live or work in the United States if the person is not a citizen of the United States or Canada;
(A) A certificate from a medical school whose curriculum is approved by the American Medical Association or its extant accreditation program for medical education, or its successor;
(B) A nonrefundable application fee as set by the board and by an examination fee prescribed in this section;
(C) Evidence of the satisfactory completion of: (i) A one-year United States training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor; or (ii) A primary specialty training program that is accredited by the Royal College of Physicians and Surgeons of Canada and that is of a duration of not less than four (4) years;
(i) A one-year United States training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor; or
(ii) A primary specialty training program that is accredited by the Royal College of Physicians and Surgeons of Canada and that is of a duration of not less than four (4) years;
(D) Sufficient evidence of good moral character; and
(E) Evidence of being legally entitled to live or work in the United States if the person is not a citizen of the United States or Canada;
(2) If an international medical school graduate: (A) A certificate from a medical school whose curriculum is judged to be acceptable by the board; (B) A copy of a permanent Educational Commission for Foreign Medical Graduates (ECFMG) certificate; (C) A nonrefundable application fee as set by the board and by an examination fee prescribed in this section; (D) Sufficient evidence of good moral character; (E) Evidence of being a citizen of the United States or Canada, or legally entitled to live or work in the United States; and (F) Evidence of satisfactory completion of a three-year post-graduate training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor. Such person may apply to the board for licensure or testing in accordance with this chapter within twelve (12) months of completion of the post-graduate training program if satisfactory performance in such program is demonstrated to the satisfaction of the board.
(A) A certificate from a medical school whose curriculum is judged to be acceptable by the board;
(B) A copy of a permanent Educational Commission for Foreign Medical Graduates (ECFMG) certificate;
(C) A nonrefundable application fee as set by the board and by an examination fee prescribed in this section;
(D) Sufficient evidence of good moral character;
(E) Evidence of being a citizen of the United States or Canada, or legally entitled to live or work in the United States; and
(F) Evidence of satisfactory completion of a three-year post-graduate training program approved by the American Medical Association or its extant accreditation program for medical education, or its successor. Such person may apply to the board for licensure or testing in accordance with this chapter within twelve (12) months of completion of the post-graduate training program if satisfactory performance in such program is demonstrated to the satisfaction of the board.
(b) All applicants shall present themselves before the board or the board's administrative designee for examination. The board may question in such subjects as the board may deem appropriate. As its qualifying examination, the board accepts the Federation Licensing Examination (FLEX), and/or the National Board of Medical Examiners examination and/or the United States Medical Licensing Examination or its successor examination. Applicants shall successfully complete the United States Medical Licensing Examination within ten (10) years from the date of whichever step of the examination was successfully completed first. An applicant is considered to have successfully completed a step of the examination on the date that the step was taken and not the date on which the passing score was made public by the examination agency; provided, however, that the board is authorized to promulgate rules and regulations creating exceptions that will extend the ten-year time frame provided in this subsection (b). In addition, the board reserves the right to write its own state board examination or contract with other national testing organizations. The board reserves the right to designate its administrative staff to administer the licensing examinations and to collect such application and examination fees as the board, in its discretion, may deem necessary.
(c) The members of the board also have the right to examine all applicants in such oral examinations as they may deem necessary.
(d) The board is authorized in its discretion to issue special training licenses to medical interns, residents and fellows who have met all other qualifications for licensure contained in this chapter and the rules and regulations promulgated pursuant thereto, with the exception of having completed the necessary residency or training programs required by subdivision (a)(1)(C) and/or (a)(2)(F) and the licensure examination. The board also is authorized to promulgate rules and regulations to implement this new licensure category. The initial set of these rules may be processed as emergency rules pursuant to the Uniform Administrative Procedures Act, compiled in title 4, chapter 5. These special training licenses will be governed by the following: (1) (A) Such licenses shall be issued only to medical interns, residents and fellows while participating in a training program of one of the accredited medical schools or of one of such medical school's affiliated teaching hospitals in Tennessee, performing duties assigned to meet the requirements of such program, and while under the supervision and control of a physician fully licensed to practice medicine in Tennessee; (B) No person holding a special training license is permitted to practice medicine outside of such person's duties and responsibilities in the training program without being fully licensed to practice medicine in Tennessee. Termination of participation in the training program for which the special license was issued for any reason terminates that license; (C) It is the responsibility of the program director or the dean responsible for the training program to submit the necessary information and applications on behalf of each applicant. It also is the responsibility of the program director or the dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason; and (D) The board may impose fees to accompany each individual application for a special training license. (2) (A) (i) Notwithstanding subdivision (d)(1), medical students, interns, residents, and clinical fellows who do not hold a special training license pursuant to this subsection (d) are exempt from the requirement of a license to practice medicine or surgery in this state when such medical students, interns, residents, and clinical fellows are participating in a training program of one (1) of the accredited medical schools or of one (1) of its affiliated teaching hospitals in this state, performing duties assigned to meet the requirements of the training program, and while under the supervision and control of a physician fully licensed to practice medicine or surgery in this state. No such student, intern, resident, or clinical fellow is permitted to practice medicine or surgery outside of the person's duties and responsibilities in the training program without being fully licensed to practice medicine or surgery in this state; (ii) It is the responsibility of the program director or the dean responsible for the training program to apply to the board for an exemption for each such medical student, intern, resident, or clinical fellow. Moreover, it is the responsibility of such program director or dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason; (B) The board may impose a fee to accompany each application for exemption; (C) Eligibility for the exemption provided for in this subdivision (d)(2) shall apply to all eligible persons in training on April 8, 1994, or thereafter.
(1) (A) Such licenses shall be issued only to medical interns, residents and fellows while participating in a training program of one of the accredited medical schools or of one of such medical school's affiliated teaching hospitals in Tennessee, performing duties assigned to meet the requirements of such program, and while under the supervision and control of a physician fully licensed to practice medicine in Tennessee; (B) No person holding a special training license is permitted to practice medicine outside of such person's duties and responsibilities in the training program without being fully licensed to practice medicine in Tennessee. Termination of participation in the training program for which the special license was issued for any reason terminates that license; (C) It is the responsibility of the program director or the dean responsible for the training program to submit the necessary information and applications on behalf of each applicant. It also is the responsibility of the program director or the dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason; and (D) The board may impose fees to accompany each individual application for a special training license.
(A) Such licenses shall be issued only to medical interns, residents and fellows while participating in a training program of one of the accredited medical schools or of one of such medical school's affiliated teaching hospitals in Tennessee, performing duties assigned to meet the requirements of such program, and while under the supervision and control of a physician fully licensed to practice medicine in Tennessee;
(B) No person holding a special training license is permitted to practice medicine outside of such person's duties and responsibilities in the training program without being fully licensed to practice medicine in Tennessee. Termination of participation in the training program for which the special license was issued for any reason terminates that license;
(C) It is the responsibility of the program director or the dean responsible for the training program to submit the necessary information and applications on behalf of each applicant. It also is the responsibility of the program director or the dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason; and
(D) The board may impose fees to accompany each individual application for a special training license.
(2) (A) (i) Notwithstanding subdivision (d)(1), medical students, interns, residents, and clinical fellows who do not hold a special training license pursuant to this subsection (d) are exempt from the requirement of a license to practice medicine or surgery in this state when such medical students, interns, residents, and clinical fellows are participating in a training program of one (1) of the accredited medical schools or of one (1) of its affiliated teaching hospitals in this state, performing duties assigned to meet the requirements of the training program, and while under the supervision and control of a physician fully licensed to practice medicine or surgery in this state. No such student, intern, resident, or clinical fellow is permitted to practice medicine or surgery outside of the person's duties and responsibilities in the training program without being fully licensed to practice medicine or surgery in this state; (ii) It is the responsibility of the program director or the dean responsible for the training program to apply to the board for an exemption for each such medical student, intern, resident, or clinical fellow. Moreover, it is the responsibility of such program director or dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason; (B) The board may impose a fee to accompany each application for exemption; (C) Eligibility for the exemption provided for in this subdivision (d)(2) shall apply to all eligible persons in training on April 8, 1994, or thereafter.
(A) (i) Notwithstanding subdivision (d)(1), medical students, interns, residents, and clinical fellows who do not hold a special training license pursuant to this subsection (d) are exempt from the requirement of a license to practice medicine or surgery in this state when such medical students, interns, residents, and clinical fellows are participating in a training program of one (1) of the accredited medical schools or of one (1) of its affiliated teaching hospitals in this state, performing duties assigned to meet the requirements of the training program, and while under the supervision and control of a physician fully licensed to practice medicine or surgery in this state. No such student, intern, resident, or clinical fellow is permitted to practice medicine or surgery outside of the person's duties and responsibilities in the training program without being fully licensed to practice medicine or surgery in this state; (ii) It is the responsibility of the program director or the dean responsible for the training program to apply to the board for an exemption for each such medical student, intern, resident, or clinical fellow. Moreover, it is the responsibility of such program director or dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason;
(i) Notwithstanding subdivision (d)(1), medical students, interns, residents, and clinical fellows who do not hold a special training license pursuant to this subsection (d) are exempt from the requirement of a license to practice medicine or surgery in this state when such medical students, interns, residents, and clinical fellows are participating in a training program of one (1) of the accredited medical schools or of one (1) of its affiliated teaching hospitals in this state, performing duties assigned to meet the requirements of the training program, and while under the supervision and control of a physician fully licensed to practice medicine or surgery in this state. No such student, intern, resident, or clinical fellow is permitted to practice medicine or surgery outside of the person's duties and responsibilities in the training program without being fully licensed to practice medicine or surgery in this state;
(ii) It is the responsibility of the program director or the dean responsible for the training program to apply to the board for an exemption for each such medical student, intern, resident, or clinical fellow. Moreover, it is the responsibility of such program director or dean to notify the board of the termination of the applicant's participation in the training program, whether by completion of the program or for any other reason;
(B) The board may impose a fee to accompany each application for exemption;
(C) Eligibility for the exemption provided for in this subdivision (d)(2) shall apply to all eligible persons in training on April 8, 1994, or thereafter.
(e) The board or the board's designee is specifically authorized to conduct applicant interviews periodically as it deems necessary on a case by case basis.
(f) (1) (A) The general assembly finds that St. Jude Children's Research Hospital is unique as a research center hospital in this state and this nation for protocol-based therapy and treatment of children and adolescents with newly diagnosed untreated or suspected cancer, HIV infections, or certain hematologic, immunologic, or genetic diseases. St. Jude Children's Research Hospital's experts are involved in research and treatment in the fields of hematology, oncology, bone marrow transplantation, immunology, genetic diseases and infectious diseases. The hospital's research involves both basic and clinical science and it is a National Cancer Institute Comprehensive Cancer Center. The general assembly finds that supporting research and treatment by qualified physicians and researchers at St. Jude Children's Research Hospital by means of a special St. Jude Children's Research Hospital global collaboration license would substantially benefit the state, the practice of medicine and the health of persons benefitting from treatment or research conducted at the hospital. (B) The board is authorized in its discretion to issue a special St. Jude Children's Research Hospital global collaboration license to physicians who have met all other qualifications for licensure contained in this chapter and the rules and regulation promulgated pursuant to this chapter, with the exception of having completed the necessary residency or training programs required by subdivision (a)(1)(C) or (a)(2)(F). The board is also authorized to promulgate rules and regulations to implement this new special licensure category. (2) These special St. Jude Children's Research Hospital global collaboration licenses will be governed by the following: (A) Such license shall be issued only to physicians while employed by St. Jude Children's Research Hospital; (B) No person holding a special St. Jude Children's Research Hospital global collaboration license is permitted to practice medicine outside of such person's duties and responsibilities as an employee of St. Jude Children's Hospital without being fully licensed to practice medicine in Tennessee. Termination of employment with St. Jude Children's Research Hospital for any reason terminates the special license; (C) It is the responsibility of St. Jude Children's Research Hospital to submit the necessary information and applications on behalf of each applicant. It is also the responsibility of St. Jude Children's Research Hospital to notify the board of the termination of the applicant's employment; and (D) The board may impose fees to accompany each individual application for this special license.
(1) (A) The general assembly finds that St. Jude Children's Research Hospital is unique as a research center hospital in this state and this nation for protocol-based therapy and treatment of children and adolescents with newly diagnosed untreated or suspected cancer, HIV infections, or certain hematologic, immunologic, or genetic diseases. St. Jude Children's Research Hospital's experts are involved in research and treatment in the fields of hematology, oncology, bone marrow transplantation, immunology, genetic diseases and infectious diseases. The hospital's research involves both basic and clinical science and it is a National Cancer Institute Comprehensive Cancer Center. The general assembly finds that supporting research and treatment by qualified physicians and researchers at St. Jude Children's Research Hospital by means of a special St. Jude Children's Research Hospital global collaboration license would substantially benefit the state, the practice of medicine and the health of persons benefitting from treatment or research conducted at the hospital. (B) The board is authorized in its discretion to issue a special St. Jude Children's Research Hospital global collaboration license to physicians who have met all other qualifications for licensure contained in this chapter and the rules and regulation promulgated pursuant to this chapter, with the exception of having completed the necessary residency or training programs required by subdivision (a)(1)(C) or (a)(2)(F). The board is also authorized to promulgate rules and regulations to implement this new special licensure category.
(A) The general assembly finds that St. Jude Children's Research Hospital is unique as a research center hospital in this state and this nation for protocol-based therapy and treatment of children and adolescents with newly diagnosed untreated or suspected cancer, HIV infections, or certain hematologic, immunologic, or genetic diseases. St. Jude Children's Research Hospital's experts are involved in research and treatment in the fields of hematology, oncology, bone marrow transplantation, immunology, genetic diseases and infectious diseases. The hospital's research involves both basic and clinical science and it is a National Cancer Institute Comprehensive Cancer Center. The general assembly finds that supporting research and treatment by qualified physicians and researchers at St. Jude Children's Research Hospital by means of a special St. Jude Children's Research Hospital global collaboration license would substantially benefit the state, the practice of medicine and the health of persons benefitting from treatment or research conducted at the hospital.
(B) The board is authorized in its discretion to issue a special St. Jude Children's Research Hospital global collaboration license to physicians who have met all other qualifications for licensure contained in this chapter and the rules and regulation promulgated pursuant to this chapter, with the exception of having completed the necessary residency or training programs required by subdivision (a)(1)(C) or (a)(2)(F). The board is also authorized to promulgate rules and regulations to implement this new special licensure category.
(2) These special St. Jude Children's Research Hospital global collaboration licenses will be governed by the following: (A) Such license shall be issued only to physicians while employed by St. Jude Children's Research Hospital; (B) No person holding a special St. Jude Children's Research Hospital global collaboration license is permitted to practice medicine outside of such person's duties and responsibilities as an employee of St. Jude Children's Hospital without being fully licensed to practice medicine in Tennessee. Termination of employment with St. Jude Children's Research Hospital for any reason terminates the special license; (C) It is the responsibility of St. Jude Children's Research Hospital to submit the necessary information and applications on behalf of each applicant. It is also the responsibility of St. Jude Children's Research Hospital to notify the board of the termination of the applicant's employment; and (D) The board may impose fees to accompany each individual application for this special license.
(A) Such license shall be issued only to physicians while employed by St. Jude Children's Research Hospital;
(B) No person holding a special St. Jude Children's Research Hospital global collaboration license is permitted to practice medicine outside of such person's duties and responsibilities as an employee of St. Jude Children's Hospital without being fully licensed to practice medicine in Tennessee. Termination of employment with St. Jude Children's Research Hospital for any reason terminates the special license;
(C) It is the responsibility of St. Jude Children's Research Hospital to submit the necessary information and applications on behalf of each applicant. It is also the responsibility of St. Jude Children's Research Hospital to notify the board of the termination of the applicant's employment; and
(D) The board may impose fees to accompany each individual application for this special license.
(g) (1) The board may issue a foreign training license of limited duration to an international medical school graduate who has successfully completed the examination as described in subsection (b) upon finding sufficient evidence that the international medical school graduate demonstrates competency as determined by the board, and: (A) Completed a postgraduate training program of a minimum of three (3) years in the graduate's licensing country; and (B) Has otherwise practiced as a medical professional performing the duties of a physician for the last three (3) years outside the United States. (2) An applicant under subdivision (g)(1) must submit sufficient evidence that the applicant is an international medical school graduate and has an offer for employment as a physician at a healthcare provider that operates in this state and has a postgraduate training program accredited by the accreditation council for graduate medical education in place. (3) An international medical school graduate who is granted a foreign training license under subdivision (g)(1) must only provide medical services at a healthcare provider that has in place a postgraduate training program accredited by the accreditation council for graduate medical education. (4) The board may grant a full and unrestricted license to practice medicine to a foreign training licensee under subdivision (g)(1) who is in good standing and has actively practiced medicine in this state for two (2) years after the date of foreign training licensure. (5) As used in this subsection (g), "healthcare provider" means an individual, entity, corporation, person, or organization, whether for profit or nonprofit, that furnishes, bills, or is paid for a healthcare procedure or service delivery in the normal course of business, and includes, but is not limited to, a health system, hospital, hospital-based facility, freestanding emergency facility, and urgent care clinic.
(1) The board may issue a foreign training license of limited duration to an international medical school graduate who has successfully completed the examination as described in subsection (b) upon finding sufficient evidence that the international medical school graduate demonstrates competency as determined by the board, and: (A) Completed a postgraduate training program of a minimum of three (3) years in the graduate's licensing country; and (B) Has otherwise practiced as a medical professional performing the duties of a physician for the last three (3) years outside the United States.
(A) Completed a postgraduate training program of a minimum of three (3) years in the graduate's licensing country; and
(B) Has otherwise practiced as a medical professional performing the duties of a physician for the last three (3) years outside the United States.
(2) An applicant under subdivision (g)(1) must submit sufficient evidence that the applicant is an international medical school graduate and has an offer for employment as a physician at a healthcare provider that operates in this state and has a postgraduate training program accredited by the accreditation council for graduate medical education in place.
(3) An international medical school graduate who is granted a foreign training license under subdivision (g)(1) must only provide medical services at a healthcare provider that has in place a postgraduate training program accredited by the accreditation council for graduate medical education.
(4) The board may grant a full and unrestricted license to practice medicine to a foreign training licensee under subdivision (g)(1) who is in good standing and has actively practiced medicine in this state for two (2) years after the date of foreign training licensure.
(5) As used in this subsection (g), "healthcare provider" means an individual, entity, corporation, person, or organization, whether for profit or nonprofit, that furnishes, bills, or is paid for a healthcare procedure or service delivery in the normal course of business, and includes, but is not limited to, a health system, hospital, hospital-based facility, freestanding emergency facility, and urgent care clinic.
(h) (1) The board may issue a temporary license of limited duration to an international medical school graduate who has successfully completed the examination as described in subsection (b) upon finding sufficient evidence that the international medical school graduate demonstrates competency as determined by the board and has completed a one-year postgraduate training program in the United States. (2) Subdivision (g)(3) does not apply to an international medical school graduate who is granted a temporary license under subdivision (h)(1). (3) The board may grant a full and unrestricted license to practice medicine to a temporary licensee under subdivision (h)(1) who is in good standing and has actively practiced medicine in this state for two (2) years after the date of temporary licensure.
(1) The board may issue a temporary license of limited duration to an international medical school graduate who has successfully completed the examination as described in subsection (b) upon finding sufficient evidence that the international medical school graduate demonstrates competency as determined by the board and has completed a one-year postgraduate training program in the United States.
(2) Subdivision (g)(3) does not apply to an international medical school graduate who is granted a temporary license under subdivision (h)(1).
(3) The board may grant a full and unrestricted license to practice medicine to a temporary licensee under subdivision (h)(1) who is in good standing and has actively practiced medicine in this state for two (2) years after the date of temporary licensure.
(i) The board is authorized in its discretion to issue limited licenses to physicians who have been out of clinical practice for an extended period of time or who have been, or are at the time of their application, engaged exclusively in administrative medicine. The board may promulgate rules prescribing any other conditions or requirements with respect to the issuance of a limited license pursuant to this subsection (i).
Amended by 2024 Tenn. Acts, ch. 929,s 1, eff. 1/1/2025.
Amended by 2023 Tenn. Acts, ch. 211, s 1, eff. 7/1/2024.
Amended by 2022 Tenn. Acts, ch. 1083, s 2, eff. 5/27/2022.
Amended by 2022 Tenn. Acts, ch. 747, s 1, eff. 3/24/2022.
Amended by 2016 Tenn. Acts, ch. 632, s 1, eff. 7/1/2016.
Amended by 2014 Tenn. Acts, ch. 949,s 6, eff. 7/1/2014.
Acts 1901, ch. 78, § 6; Shan., § 3609a18; Code 1932, § 6923; Acts 1945, ch. 181, § 3; C. Supp. 1950, § 6923; Acts 1975, ch. 355, § 14; impl. am. Acts 1976, ch. 575, § 1; T.C.A. (orig. ed.), § 63-611; Acts 1982, ch. 905, § 4; 1985, ch. 468, §§ 1, 2; 1988, ch. 912, § 1; 1989, ch. 302, § 1; 1989, ch. 523, §§ 41, 42; 1990, ch. 1002, § 1; 1990, ch. 1055, §§ 1, 3; 1993, ch. 404, § 8; 1994, ch. 732, § 2; 1995, ch. 97, §§ 1-3; 1995, ch. 329, § 1; 1998, ch. 877, § 1; 2003 , ch. 11, § 1; 2004, ch. 562, § 1; 2006, ch. 774, §§ 1, 2; 2009 , ch. 566, § 12; 2010 , ch. 724, § 1; 2010 , ch. 976, § 1.
Tenn. Code Ann. § 63-23-105 — TN Code / Title 63 / Chapter 23 / Section 63-23-105
Practice of advanced master's or doctorate social work as licensed clinical social worker - Licensing requirements
Status: in_force

(a) The practice of advanced master's or doctorate social work as a licensed clinical social worker is a specialty within the practice of social work that requires the application of social work theory, knowledge, methods, principles, values, ethics, and the professional use of self to restore or enhance social, psychosocial or biopsychosocial functioning of individuals, couples, families, groups or persons who are adversely affected by social or psychosocial stress or health impairment. The practice of clinical social work requires the application of specialized clinical knowledge and advanced clinical skills in the areas of assessment, diagnosis and treatment of mental, emotional and behavioral disorders, conditions and addictions, including severe mental illness in adults and serious emotional disturbances in children, case management, direct practice, information and referral, clinical and nonclinical supervision, and the development, implementation, and administration of policies, programs and activities. Treatment methods include the provision of individual, marital, couple, family, and group therapy, mediation, counseling, supportive counseling, advanced case management, direct practice and psychotherapy. Clinical social workers are qualified to use the Diagnostic and Statistical Manual of Mental Disorders (DSM), the International Classification of Diseases (ICD), and other diagnostic classification systems in assessment, diagnosis, treatment planning and other activities. The advanced practice of clinical social work may occur outside the jurisdiction of an agency or organizational setting in which the social worker assumes responsibility and accountability for the nature and quality of the services provided to clients, pro bono or in exchange for direct payment or third-party reimbursement. Practice at this level may include the provision of supervision for licensed or temporarily licensed master's social workers seeking advanced licensure as an advanced practice social worker or as a licensed clinical social worker. Licensed clinical social workers may engage in both independent clinical and agency-based, nonclinical, macro social work practice. A social worker may not prescribe medication or interpret psychological tests. The practice of advanced master's or doctorate social work as a licensed clinical social worker may include the practice activities of a licensed baccalaureate social worker, licensed master's social worker and/or licensed advanced practice social worker. (b) To obtain a license to engage in the practice independently as a licensed clinical social worker an applicant must provide evidence satisfactory to the board that the applicant has: (1) Submitted a written application in a form prescribed by the board or via online application; (2) Paid all applicable fees specified by the board relative to the licensure process; (3) Attained the age of majority; (4) Graduated and received a master's degree in social work from a council on social work education approved program or has received a doctorate or Ph.D. in social work; (5) Worked for not less than two (2) years as a licensed master's social worker, or temporarily licensed master's social worker under the supervision of a licensed clinical social worker or, if the applicant is from another state, has worked for not less than two (2) years prior to the date of application under the supervision of a person who possesses educational and experiential qualifications that meet or exceed the requirements for licensure in this state as a licensed clinical social worker; and (6) Successfully passed the association of social work board's clinical licensing exam. (c) No person shall practice independently as a clinical social worker or act as, or represent the person to be, a licensed clinical social worker as defined in this section unless the person possesses a valid license issued pursuant to subsection (b). (d) A violation of subsection (c) is a Class A misdemeanor. Amended by 2014 Tenn. Acts, ch. 949,s 14, eff. 7/1/2014. Acts 2008 , ch. 1016, § 1.
(a) The practice of advanced master's or doctorate social work as a licensed clinical social worker is a specialty within the practice of social work that requires the application of social work theory, knowledge, methods, principles, values, ethics, and the professional use of self to restore or enhance social, psychosocial or biopsychosocial functioning of individuals, couples, families, groups or persons who are adversely affected by social or psychosocial stress or health impairment. The practice of clinical social work requires the application of specialized clinical knowledge and advanced clinical skills in the areas of assessment, diagnosis and treatment of mental, emotional and behavioral disorders, conditions and addictions, including severe mental illness in adults and serious emotional disturbances in children, case management, direct practice, information and referral, clinical and nonclinical supervision, and the development, implementation, and administration of policies, programs and activities. Treatment methods include the provision of individual, marital, couple, family, and group therapy, mediation, counseling, supportive counseling, advanced case management, direct practice and psychotherapy. Clinical social workers are qualified to use the Diagnostic and Statistical Manual of Mental Disorders (DSM), the International Classification of Diseases (ICD), and other diagnostic classification systems in assessment, diagnosis, treatment planning and other activities. The advanced practice of clinical social work may occur outside the jurisdiction of an agency or organizational setting in which the social worker assumes responsibility and accountability for the nature and quality of the services provided to clients, pro bono or in exchange for direct payment or third-party reimbursement. Practice at this level may include the provision of supervision for licensed or temporarily licensed master's social workers seeking advanced licensure as an advanced practice social worker or as a licensed clinical social worker. Licensed clinical social workers may engage in both independent clinical and agency-based, nonclinical, macro social work practice. A social worker may not prescribe medication or interpret psychological tests. The practice of advanced master's or doctorate social work as a licensed clinical social worker may include the practice activities of a licensed baccalaureate social worker, licensed master's social worker and/or licensed advanced practice social worker.
(b) To obtain a license to engage in the practice independently as a licensed clinical social worker an applicant must provide evidence satisfactory to the board that the applicant has: (1) Submitted a written application in a form prescribed by the board or via online application; (2) Paid all applicable fees specified by the board relative to the licensure process; (3) Attained the age of majority; (4) Graduated and received a master's degree in social work from a council on social work education approved program or has received a doctorate or Ph.D. in social work; (5) Worked for not less than two (2) years as a licensed master's social worker, or temporarily licensed master's social worker under the supervision of a licensed clinical social worker or, if the applicant is from another state, has worked for not less than two (2) years prior to the date of application under the supervision of a person who possesses educational and experiential qualifications that meet or exceed the requirements for licensure in this state as a licensed clinical social worker; and (6) Successfully passed the association of social work board's clinical licensing exam.
(1) Submitted a written application in a form prescribed by the board or via online application;
(2) Paid all applicable fees specified by the board relative to the licensure process;
(3) Attained the age of majority;
(4) Graduated and received a master's degree in social work from a council on social work education approved program or has received a doctorate or Ph.D. in social work;
(5) Worked for not less than two (2) years as a licensed master's social worker, or temporarily licensed master's social worker under the supervision of a licensed clinical social worker or, if the applicant is from another state, has worked for not less than two (2) years prior to the date of application under the supervision of a person who possesses educational and experiential qualifications that meet or exceed the requirements for licensure in this state as a licensed clinical social worker; and
(6) Successfully passed the association of social work board's clinical licensing exam.
(c) No person shall practice independently as a clinical social worker or act as, or represent the person to be, a licensed clinical social worker as defined in this section unless the person possesses a valid license issued pursuant to subsection (b).
(d) A violation of subsection (c) is a Class A misdemeanor.
Amended by 2014 Tenn. Acts, ch. 949,s 14, eff. 7/1/2014.
Acts 2008 , ch. 1016, § 1.
Tenn. Code Ann. § 63-13-306 — TN Code / Title 63 / Chapter 13 / Section 63-13-306
Application - Examinations
Status: in_force

(a) (1) An applicant for licensure as a physical therapist or physical therapist assistant shall file an application as required by the board. A nonrefundable application fee and cost of the examination shall accompany the completed written or online application. Fees shall be established by the rules promulgated by the board. (2) (A) When the board receives a completed application for initial licensure from an applicant, then the board shall, within sixty (60) days from the date the board receives the completed application: (i) Render a decision on the application; or (ii) Inform the applicant of the need to appear before the board. (B) As used in this subdivision (a)(2), "completed application" means an application that satisfies all statutory and board rule requirements. (b) After the application process has been completed, an applicant shall take the examination for physical therapist licensure that covers current physical therapy practice. (c) After the application process has been completed, an applicant shall take the examination for physical therapist assistant licensure that covers current technical application of physical therapy services. (d) Examinations shall be available within the state at such time and place as the board shall determine. The board shall determine the passing score. (e) Applicants who do not pass the examination after the first attempt may retake the examination one (1) additional time without reapplication for licensure up to a total of six (6) attempts. Applications remain active for twelve (12) months. After twelve (12) months, applicants must submit a new application with all applicable fees. Amended by 2023 Tenn. Acts, ch. 426, s 13, eff. 5/11/2023. Amended by 2020 Tenn. Acts, ch. 790, s 7, eff. 7/15/2020. Amended by 2014 Tenn. Acts, ch. 949,s 11, eff. 7/1/2014. Acts 1999, ch. 528, § 17; 2007 , ch. 115, § 10.
(a) (1) An applicant for licensure as a physical therapist or physical therapist assistant shall file an application as required by the board. A nonrefundable application fee and cost of the examination shall accompany the completed written or online application. Fees shall be established by the rules promulgated by the board. (2) (A) When the board receives a completed application for initial licensure from an applicant, then the board shall, within sixty (60) days from the date the board receives the completed application: (i) Render a decision on the application; or (ii) Inform the applicant of the need to appear before the board. (B) As used in this subdivision (a)(2), "completed application" means an application that satisfies all statutory and board rule requirements.
(1) An applicant for licensure as a physical therapist or physical therapist assistant shall file an application as required by the board. A nonrefundable application fee and cost of the examination shall accompany the completed written or online application. Fees shall be established by the rules promulgated by the board.
(2) (A) When the board receives a completed application for initial licensure from an applicant, then the board shall, within sixty (60) days from the date the board receives the completed application: (i) Render a decision on the application; or (ii) Inform the applicant of the need to appear before the board. (B) As used in this subdivision (a)(2), "completed application" means an application that satisfies all statutory and board rule requirements.
(A) When the board receives a completed application for initial licensure from an applicant, then the board shall, within sixty (60) days from the date the board receives the completed application: (i) Render a decision on the application; or (ii) Inform the applicant of the need to appear before the board.
(i) Render a decision on the application; or
(ii) Inform the applicant of the need to appear before the board.
(B) As used in this subdivision (a)(2), "completed application" means an application that satisfies all statutory and board rule requirements.
(b) After the application process has been completed, an applicant shall take the examination for physical therapist licensure that covers current physical therapy practice.
(c) After the application process has been completed, an applicant shall take the examination for physical therapist assistant licensure that covers current technical application of physical therapy services.
(d) Examinations shall be available within the state at such time and place as the board shall determine. The board shall determine the passing score.
(e) Applicants who do not pass the examination after the first attempt may retake the examination one (1) additional time without reapplication for licensure up to a total of six (6) attempts. Applications remain active for twelve (12) months. After twelve (12) months, applicants must submit a new application with all applicable fees.
Amended by 2023 Tenn. Acts, ch. 426, s 13, eff. 5/11/2023.
Amended by 2020 Tenn. Acts, ch. 790, s 7, eff. 7/15/2020.
Amended by 2014 Tenn. Acts, ch. 949,s 11, eff. 7/1/2014.
Acts 1999, ch. 528, § 17; 2007 , ch. 115, § 10.